Generex Biotechnology Stock Predictions

Healthcare > Biotechnology

Buy GNBT

*Your capital is at risk

$0.0006

+0 (+0%)

At Close: Feb 07, 2023

Currently predicting for Tue, 16 Jun 2026

GNBT Live board

Community Bull/Bear

Target Next close

Join the GNBT prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

GNBT Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For GNBT

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

GNBT Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT GENEREX BIOTECHNOLOGY CORP

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
IDYA $28.84	4.82%	Jun 11
EAT $140.46	11.23%	Jun 05
TPR $140.47	7.49%	Jun 04
LITE $905.00	5.77%	Jun 01
W WCLD $27.34	12.84%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by